Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Species of Ancistrus (Siluriformes, Loricariidae) from Ecuador, with the description of a new species from the Amazon River Basin.

Provenzano R F, Barriga-Salazar R.

Zootaxa. 2018 Dec 4;4527(2):211-238. doi: 10.11646/zootaxa.4527.2.4.

PMID:
30651463
2.

A new species of the catfish genus <i>Cordylancistrus</i> (Siluriformes, Loricariidae) from the Sierra Nevada de Santa Marta, Colombia.

Provenzano R F, Milani N, Ardila R C.

Zootaxa. 2017 Oct 4;4329(3):256-266. doi: 10.11646/zootaxa.4329.3.4.

PMID:
29242476
3.

The species of Hemiancistrus (Siluriformes: Loricariidae) from Ecuador.

Provenzano R F, Barriga S R.

Zootaxa. 2017 May 29;4272(2):221-235. doi: 10.11646/zootaxa.4272.2.4.

PMID:
28610292
4.

AKI moves into the outpatient dialysis setting. What the new law means for patients, staff.

Provenzano R, Payne G.

Nephrol News Issues. 2017 Feb;31(2):27-29. No abstract available.

PMID:
30408407
5.

The Economics of Late-Stage Chronic Kidney Disease.

Provenzano R.

Adv Chronic Kidney Dis. 2016 Jul;23(4):222-6. doi: 10.1053/j.ackd.2015.12.002. Review.

PMID:
27324674
6.

Viewpoint: Is there a nephrologist shortage or just poor deployment?

Provenzano R.

Nephrol News Issues. 2016 Apr;30(4):34-6. No abstract available.

PMID:
27257658
7.

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.

Provenzano R, Besarab A, Sun CH, Diamond SA, Durham JH, Cangiano JL, Aiello JR, Novak JE, Lee T, Leong R, Roberts BK, Saikali KG, Hemmerich S, Szczech LA, Yu KH, Neff TB.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):982-91. doi: 10.2215/CJN.06890615. Epub 2016 Apr 19.

8.

Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study.

Provenzano R, Besarab A, Wright S, Dua S, Zeig S, Nguyen P, Poole L, Saikali KG, Saha G, Hemmerich S, Szczech L, Yu KH, Neff TB.

Am J Kidney Dis. 2016 Jun;67(6):912-24. doi: 10.1053/j.ajkd.2015.12.020. Epub 2016 Feb 2.

9.

Prospective analysis of Hemodialysis Reliable Outflow (HeRO) vascular access graft vs. cuffed catheter access in hemodialysis.

Provenzano R, LaFleur P, McFadden L, LaFleur M, Lorelli D.

Nephrol News Issues. 2015 Nov;29(12):30-3, 37, 42-4.

PMID:
26677595
10.

Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients.

Besarab A, Provenzano R, Hertel J, Zabaneh R, Klaus SJ, Lee T, Leong R, Hemmerich S, Yu KH, Neff TB.

Nephrol Dial Transplant. 2015 Oct;30(10):1665-73. doi: 10.1093/ndt/gfv302. Epub 2015 Aug 3.

11.

Introduction: Role of the medical director series.

Provenzano R, Hymes JL.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):325. doi: 10.2215/CJN.11811214. Epub 2015 Jan 12. No abstract available.

12.

Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.

Macdougall IC, Provenzano R, Sharma A, Spinowitz BS, Schmidt RJ, Pergola PE, Zabaneh RI, Tong-Starksen S, Mayo MR, Tang H, Polu KR, Duliege AM, Fishbane S; PEARL Study Groups.

N Engl J Med. 2013 Jan 24;368(4):320-32. doi: 10.1056/NEJMoa1203166.

13.

Peginesatide in patients with anemia undergoing hemodialysis.

Fishbane S, Schiller B, Locatelli F, Covic AC, Provenzano R, Wiecek A, Levin NW, Kaplan M, Macdougall IC, Francisco C, Mayo MR, Polu KR, Duliege AM, Besarab A; EMERALD Study Groups.

N Engl J Med. 2013 Jan 24;368(4):307-19. doi: 10.1056/NEJMoa1203165.

14.

Early cell changes and TGFβ pathway alterations in the aortopathy associated with bicuspid aortic valve stenosis.

Forte A, Della Corte A, Grossi M, Bancone C, Provenzano R, Finicelli M, De Feo M, De Santo LS, Nappi G, Cotrufo M, Galderisi U, Cipollaro M.

Clin Sci (Lond). 2013 Jan;124(2):97-108.

PMID:
22857993
15.

Apico-aortic conduit for severe hypertrophic cardiomyopathy: sudden death despite conduit patency 31 years postoperatively.

Nappi G, Dialetto G, De Feo M, Provenzano R, Cotrufo M, Santè P, Della Corte A.

Ann Thorac Cardiovasc Surg. 2013;19(1):63-6. Epub 2012 Jun 29.

16.

Coronary artery bypass grafting associated to aortic valve replacement in the elderly: survival and quality of life.

Vicchio M, Feo MD, Giordano S, Provenzano R, Cotrufo M, Nappi G.

J Cardiothorac Surg. 2012 Feb 6;7:13. doi: 10.1186/1749-8090-7-13.

17.

Lack of definite indication criteria for choosing between transcatheter implantation and surgical replacement of the aortic valve.

De Feo M, Vicchio M, Della Corte A, Provenzano R, Giordano S, Amendolara F, Montibello M, Nappi G, Cotrufo M.

J Cardiovasc Med (Hagerstown). 2013 Feb;14(2):158-63. doi: 10.2459/JCM.0b013e32834eed0d.

PMID:
22157181
18.

Morphological and molecular characterization of healthy human ascending aorta.

Forte A, Della Corte A, Grossi M, Finicelli M, Bancone C, Provenzano R, Pepino P, Nappi GA, De Feo M, Galderisi U, Cotrufo M, Cipollaro M.

Histol Histopathol. 2012 Jan;27(1):103-12. doi: 10.14670/HH-27.103.

PMID:
22127602
19.

Long-term follow-up of reduction ascending aortoplasty with autologous partial wrapping: for which patient is waistcoat aortoplasty best suited?

Della Corte A, De Feo M, Bancone C, Provenzano R, Giordano S, Buonocore M, Nappi G, Cotrufo M.

Interact Cardiovasc Thorac Surg. 2012 Jan;14(1):56-63. doi: 10.1093/icvts/ivr007. Epub 2011 Nov 15.

20.

C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis.

Roger SD, Locatelli F, Woitas RP, Laville M, Tobe SW, Provenzano R, Golper TA, Ruangkanchanasetr P, Lee HY, Wu KD, Nowicki M, Ladanyi A, Martínez-Castelao A, Beyer U, Dougherty FC.

Nephrol Dial Transplant. 2011 Dec;26(12):3980-6. doi: 10.1093/ndt/gfr160. Epub 2011 Apr 19.

21.

Relationship among length of facility ownership, clinical performance, and mortality.

Van Wyck D, Robertson J, Nissenson A, Provenzano R, Kogod D.

Clin J Am Soc Nephrol. 2010 Feb;5(2):248-51. doi: 10.2215/CJN.03700609. Epub 2009 Dec 10.

22.

Improved 24-hour blood pressure control with sirolimus versus calcineurin inhibitor based immunosuppression in renal transplant recipients.

Steigerwalt SP, Brar N, Dhungel A, Butcher D, Steigerwalt S, El-Ghouroury M, Provenzano R.

Transplant Proc. 2009 Dec;41(10):4184-7. doi: 10.1016/j.transproceed.2009.07.109.

PMID:
20005365
23.

Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients.

Provenzano R, Schiller B, Rao M, Coyne D, Brenner L, Pereira BJ.

Clin J Am Soc Nephrol. 2009 Feb;4(2):386-93. doi: 10.2215/CJN.02840608. Epub 2009 Jan 28.

24.

Aortic valve replacement with 19-mm bileaflet prostheses in the elderly: left ventricular mass regression and quality of life.

Vicchio M, De Santo LS, Della Corte A, De Feo M, Provenzano R, Miraglia M, Scardone M, Cotrufo M.

J Heart Valve Dis. 2008 Mar;17(2):216-21.

PMID:
18512494
25.

Postdialysis outcomes associated with consistent anemia treatment in predialysis patients with chronic kidney disease.

Wish JB, Nassar GM, Schulman K, del Aguila M, Provenzano R.

Clin Nephrol. 2008 Apr;69(4):251-9.

PMID:
18397699
26.

C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial.

Macdougall IC, Walker R, Provenzano R, de Alvaro F, Locay HR, Nader PC, Locatelli F, Dougherty FC, Beyer U; ARCTOS Study Investigators.

Clin J Am Soc Nephrol. 2008 Mar;3(2):337-47. doi: 10.2215/CJN.00480107. Epub 2008 Feb 20.

27.

A case of cardiac compression by hepatic cyst in a woman with polycystic kidney disease.

Li Vecchi M, Buscemi S, Nardi E, Azzolina V, Provenzano R.

Intern Emerg Med. 2008 Mar;3(1):69-71. doi: 10.1007/s11739-008-0096-4. Epub 2008 Feb 7. No abstract available.

PMID:
18256888
28.

Hemostasis factors and aging.

Mari D, Coppola R, Provenzano R.

Exp Gerontol. 2008 Feb;43(2):66-73. Epub 2007 Jul 4. Review.

PMID:
17869046
29.

Chronic kidney disease: common, harmful, and treatable--World Kidney Day 2007.

Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ.

Clin J Am Soc Nephrol. 2007 Mar;2(2):401-5. Epub 2007 Feb 7. No abstract available.

30.
31.

The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.

Provenzano R, Besarab A, Macdougall IC, Ellison DH, Maxwell AP, Sulowicz W, Klinger M, Rutkowski B, Correa-Rotter R, Dougherty FC; BA 16528 Study Investigators.

Clin Nephrol. 2007 May;67(5):306-17.

PMID:
17542340
32.

Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs.

Brancaccio D, Cozzolino M, Galassi A, Chiarelli G, Butti A, Bellasi A, Rocca-Rey L, Volpi A, Anelli A, Zoni U, Fusaro M, Brambilla C, Missaglia E, Crovetto C, Russo M, Longhini C, Provenzano R, Incalcaterra F, Cerasola G, Li Vecchi M, Gallieni M.

J Nephrol. 2007 Jan-Feb;20(1):3-9. Review.

PMID:
17347966
33.

Role of aldosterone in left ventricular hypertrophy among African-American patients with end-stage renal disease on hemodialysis.

Steigerwalt S, Zafar A, Mesiha N, Gardin J, Provenzano R.

Am J Nephrol. 2007;27(2):159-63. Epub 2007 Feb 23.

PMID:
17317951
34.

Chronic kidney disease: common, harmful and treatable--World Kidney Day 2007.

Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ.

Am J Nephrol. 2007;27(1):108-12. Epub 2007 Feb 15. Review. No abstract available.

PMID:
17308371
35.

CKD: common, harmful, and treatable--World Kidney Day 2007.

Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ.

Am J Kidney Dis. 2007 Feb;49(2):175-9. Review. No abstract available.

PMID:
17261418
36.

Chronic kidney disease: common, harmful and treatable--World Kidney Day 2007.

Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ.

Pediatr Nephrol. 2007 Mar;22(3):321-5. Epub 2007 Jan 26. No abstract available.

PMID:
17256125
37.

Chronic kidney disease: common, harmful, and treatable--World Kidney Day 2007.

Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ.

J Am Soc Nephrol. 2007 Feb;18(2):374-8. Epub 2007 Jan 17. No abstract available.

38.

Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency.

Li Vecchi M, Fuiano G, Francesco M, Mancuso D, Faga T, Sponton A, Provenzano R, Andreucci M, Tozzo C.

Nephron Clin Pract. 2007;105(2):c62-7. Epub 2006 Nov 29.

PMID:
17135770
39.

Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa.

Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, Cremieux PY.

Curr Med Res Opin. 2006 Oct;22(10):1929-37.

PMID:
17022852
40.

Prevalence and treatment of anemia with once-weekly epoetin alfa in patients with diabetes and chronic kidney disease.

Lorber DL, Provenzano R, McClellan W.

Endocr Pract. 2006 Sep-Oct;12(5):506-13.

PMID:
17002925
41.

Paying fairly for good outcomes: which formula works?

Provenzano R.

Nephrol News Issues. 2005 Oct;19(11):62-3, 84. Review.

PMID:
16270738
42.

Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT study.

Provenzano R, Bhaduri S, Singh AK; PROMPT Study Group.

Clin Nephrol. 2005 Aug;64(2):113-23.

PMID:
16114787
43.

A single center experience in the use of polyurethaneurea arteriovenous grafts.

Jefic D, Reddy PP, Flynn LM, Provenzano R.

Nephrol News Issues. 2005 Jul;19(8):44-7.

PMID:
16104342
44.

Resting metabolic rate and respiratory quotient in human longevity.

Rizzo MR, Mari D, Barbieri M, Ragno E, Grella R, Provenzano R, Villa I, Esposito K, Giugliano D, Paolisso G.

J Clin Endocrinol Metab. 2005 Jan;90(1):409-13. Epub 2004 Oct 13.

45.

Once-weekly epoetin alfa for treating the anemia of chronic kidney disease.

Provenzano R, Garcia-Mayol L, Suchinda P, Von Hartitzsch B, Woollen SB, Zabaneh R, Fink JC; POWER Study Group.

Clin Nephrol. 2004 Jun;61(6):392-405.

PMID:
15224803
46.

Economics of clinical nephrology practice.

Provenzano R, Nissenson AR.

Am J Kidney Dis. 2004 Jul;44(1):168-78. No abstract available.

PMID:
15211450
47.

Early detection of prostate cancer in the ESRD population.

Khairullah QT, Pamatmat SD, Chatha M, Provenzano R, Telang D, Temple M.

Clin Nephrol. 2004 May;61(5):308-15.

PMID:
15182125
48.

Epoetin alfa. Clinical evolution of a pleiotropic cytokine.

Henry DH, Bowers P, Romano MT, Provenzano R.

Arch Intern Med. 2004 Feb 9;164(3):262-76. Review.

PMID:
14769622
49.

The value of integrating a vascular surgeon into a nephrology practice.

Provenzano R, Flynn LM.

Nephrol News Issues. 2003 Jul;17(8):49-53. No abstract available.

PMID:
12882112
50.

Treating chronic kidney disease.

Provenzano R.

Manag Care. 2003 Apr;Spec No:3-7; discussion 17-20. No abstract available.

PMID:
12751137

Supplemental Content

Loading ...
Support Center